1 – 10 of 50
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2025
-
Mark
The genomic landscape of relapsed infant and childhood KMT2A-rearranged acute leukemia
- Contribution to journal › Article
- 2024
-
Mark
Molecular basis for human aquaporin inhibition
- Contribution to journal › Article
-
Mark
Precision Diagnostics in Myeloid Malignancies : Development and Validation of a National Capture-Based Gene Panel
- Contribution to journal › Article
-
Mark
Sequential drug treatment targeting cell cycle and cell fate regulatory programs blocks non-genetic cancer evolution in acute lymphoblastic leukemia
- Contribution to journal › Article
-
Mark
Activating mutations remodel the chromatin accessibility landscape to drive distinct regulatory networks in KMT2A-rearranged acute leukemia
- Contribution to journal › Article
-
Mark
SMS121, a new inhibitor of CD36, impairs fatty acid uptake and viability of acute myeloid leukemia
- Contribution to journal › Article
- 2023
-
Mark
Combined GLUT1 and OXPHOS inhibition eliminates acute myeloid leukemia cells by restraining their metabolic plasticity
- Contribution to journal › Article
- 2022
-
Mark
Transcriptomics paving the way for improved diagnostics and precision medicine of acute leukemia
- Contribution to journal › Article
-
Mark
Aquaglyceroporins and orthodox aquaporins in human adipocytes
- Contribution to journal › Article
-
Mark
Duplex Sequencing Uncovers Recurrent Low-frequency Cancer-associated Mutations in Infant and Childhood KMT2A-rearranged Acute Leukemia
- Contribution to journal › Article
